Performance of applied biosystems ViroSeq HIV-1 genotyping system for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda

Journal of Clinical Microbiology

Volumn 39, Issue 12, 2001, Pages 4323-4327

  Mracna, M ^a   Becker Pergola, G ^a   Dileanis, J ^a   Guay, L A ^a   Cunningham, S ^a   Jackson, J B ^a   Eshleman, S H ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UGANDA; VIRAL GENETICS; VIRUS CHARACTERIZATION; VIRUS LOAD;

ANTI-HIV AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; NEVIRAPINE; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REVERSE TRANSCRIPTASE INHIBITORS; SEQUENCE ANALYSIS, DNA; UGANDA;

EID: 0035209291     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.12.4323-4327.2001     Document Type: Article

References (22)

1. Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility
2. Analysis of HIV-1 protease and reverse tran scriptase in antiretroviral drug naive Ugandan adults
3. Identification of diverse HIV-1 subtypes and dual HIV-1 infection in pregnant Ugandan women
4. Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda
5. Detec tion of diverse HIV-1 genetic subtypes in the USA
6. Performance of the Applied Biosystems ViroSeq HIV-1 Genotyping System for analysis of HIV-1 in pediatric plasma samples
7. Prevalence of HIV-1 subtypes in France, 1996-1997, consequences for viral monitoring
8. Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors
9. Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses
10. Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors
11. Impact of HIV-1 subtype on women receiving single dose NVP prophylaxis to prevent HIV-1 vertical transmission (HIVNET 012)
12. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmis sion (HIVNET 012)
13. HIV-1 sequence subtype D in the United States
14. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-infant transmission of HIV-1 in Kampala, Uganda: HIVNET-012 randomised trial
15. Predominance of HIV-1 subtype A and D infections in Uganda
16. Presence of human immunodeficiency virus (HIV) type 1 sub type A infection in a New York community with high HIV prevalence: A sentinel site for monitoring HIV genetic diversity in North America
17. Identification of HIV-1 subtype G from Uganda
18. Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resis tance in protease inhibitor-naive individuals worldwide
19. Characterization of the reverse transcriptase of a human immunode ficiency virus type I group O isolate
20. A molecular epidemiologic survey of HIV in Uganda
21. HIV-1 group O infection identified in USA
22. Genetic diversity of protease and reverse tran scriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: Evidence of many minor drug resistance mutations in treatment naive patients